Cyclooxygenase-2 inhibitor nimesulide blocks ultraviolet B-induced photocarcinogenesis in SKH-1 hairless mice

Photochemistry and Photobiology

Volumn 84, Issue 2, 2008, Pages 522-527

  Tang, Xiuwei ^a   Kim, Arianna L ^a   Kopelovich, Levy ^b   Bickers, David R ^a   Athar, Mohammad ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; NIMESULIDE; PROSTAGLANDIN SYNTHASE INHIBITOR; SULFONAMIDE;

ANIMAL; ARTICLE; DRUG EFFECT; FEMALE; HAIRLESS MOUSE; MOUSE; RADIATION INJURY; SKIN TUMOR; ULTRAVIOLET RADIATION;

ANIMALS; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; FEMALE; MICE; MICE, INBRED HRS; NEOPLASMS, RADIATION-INDUCED; SKIN NEOPLASMS; SULFONAMIDES; ULTRAVIOLET RAYS;

ANIMALIA; MURINAE; MUS;

EID: 41049086560     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2008.00303.x     Document Type: Article

References (31)

1. Miller, D. L. M. A. Weinstock (1994) Nonmelanoma skin cancer in the United States: Incidence. J. Am. Acad. Dermatol. 30, 774 778.
2. Rigel, D. S., R. J. Friedman A. W. Kopf (1996) Lifetime risk for development of skin cancer in the U.S. population: Current estimate is now 1 in 5. J. Am. Acad. Dermatol. 35, 1012 1013.
3. Sarasin, A. (1999) The molecular pathways of ultraviolet-induced carcinogenesis. Mutat. Res. 428, 5 10.
4. Brash, D. E., J. A. Rudolph, J. A. Simon, A. Lin, G. J. McKenna, H. P. Baden, A. J. Halperin J. Ponten (1991) A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl Acad. Sci. USA 88, 10124 10128.
5. Wikonkal, N. M. D. E. Brash (1999) Ultraviolet radiation induced signature mutations in photocarcinogenesis. J. Investig. Dermatol. Symp. Proc. 4, 6 10.
6. Nelson, M. A., J. G. Einspahr, D. S. Alberts, C. A. Balfour, J. A. Wymer, K. L. Welch, S. J. Salasche, J. L. Bangert, T. M. Grogan P. O. Bozzo (1994) Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. Cancer Lett. 85, 23 29.
7. Athar, M. (2002) Oxidative stress and experimental carcinogenesis. Indian J. Exp. Biol. 40, 656 667.
8. Lee, J. L., H. Mukhtar, D. R. Bickers, L. Kopelovich M. Athar (2003) Cyclooxygenases in the skin: Pharmacological and toxicological implications. Toxicol. Appl. Pharmacol. 192, 294 306.
9. An, K. P., M. Athar, X. Tang, S. K. Katiyar, J. Russo, J. Beech, M. Aszterbaum, L. Kopelovich, E. H. Epstein Jr., H. Mukhtar D. R. Bickers (2002) Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: Implications for therapeutic approaches. Photochem. Photobiol. 76, 73 80.
10. Athar, M., K. P. An, K. D. Morel, A. L. Kim, M. Aszterbaum, J. Longley, E. H. Epstein Jr. D. R. Bickers (2001) Ultraviolet B(UVB)-induced cox-2 expression in murine skin: An immunohistochemical study. Biochem. Biophys. Res. Commun. 280, 1042 1047.
11. Lee, J. L., A. Kim, L. Kopelovich, D. R. Bickers M. Athar (2005) Differential expression of E prostanoid receptors in murine and human non-melanoma skin cancer. J. Invest. Dermatol. 125, 818 825.
12. Orengo, I. F., J. Gerguis, R. Phillips, A. Guevara, A. T. Lewis H. S. Black (2002) Celecoxib, a cyclooxygenase 2 inhibitor as a potential chemopreventive to UV-induced skin cancer: A study in the hairless mouse model. Arch. Dermatol. 138, 751 755.
13. Pentland, A. P., J. W. Schoggins, G. A. Scott, K. N. M. Khan R. Han (1999) Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis 20, 1939 1944.
14. Fischer, S. M. (2002) Is cyclooxygenase-2 important in skin carcinogenesis? J. Environ. Pathol. Toxicol. Oncol. 21, 183 191.
15. Cen, Y. Y. (2007) Letter by Cen regarding article, "Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas." Circulation 115, e348 author reply e349.
16. Bickers, D. R. M. Athar (2000) Novel approaches to chemoprevention of skin cancer. J. Dermatol. 27, 691 695.
17. Waskewich, C., R. D. Blumenthal, H. Li, R. Stein, D. M. Goldenberg J. Burton (2002) Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines. Cancer Res. 62, 2029 2033.
18. Tsujii, M. R. N. DuBois (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83, 493 501.
19. Renard, J. F., F. Julemont, X. de Leval B. Pirotte (2006) The use of nimesulide and its analogues in cancer chemoprevention. Anticancer Agents Med. Chem. 6, 233 237.
20. Wilgus, T. A., M. L. Parrett, M. S. Ross, K. L. Tober, F. M. Robertson T. M. Oberyszyn (2002) Inhibition of ultraviolet light B-induced cutaneous inflammation by a specific cyclooxygenase-2 inhibitor. Adv. Exp. Med. Biol. 507, 85 92.
21. Athar, M., K. P. An, X. Tang, K. D. Morel, A. L. Kim, L. Kopelovich D. R. Bickers (2004) Photoprotective effects of sulindac against ultraviolet B-induced phototoxicity in the skin of SKH-1 hairless mice. Toxicol. Appl. Pharmacol. 195, 370 378.
22. Fischer, S. M., H. H. Lo, G. B. Gordon, K. Seibert, G. Kelloff, R. A. Lubet C. J. Conti (1999) Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol. Carcinog. 25, 231 240.
23. Breitner, J. C., B. K. Martin C. L. Meinert (2006) The suspension of treatments in ADAPT: Concerns beyond the cardiovascular safety of celecoxib or naproxen. PLoS Clin. Trials 1, e41.
24. Rozic, J. G., C. Chakraborty P. K. Lala (2001) Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis. Int. J. Cancer 93, 497 506.
25. Ferrandina, G., F. O. Ranelletti, F. Legge, L. Lauriola, V. Salutari, M. Gessi, A. C. Testa, U. Werner, P. Navarra, G. Tringali, A. Battaglia G. Scambia (2003) Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: A pilot study. Clin. Cancer Res. 9, 4324 4331.
26. Sheng, H., J. Shao, J. D. Morrow, R. D. Beauchamp R. N. DuBois (1998) Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res. 58, 362 366.
27. Rao, D. S., D. Gui, M. E. Koski, L. M. Popoviciu, H. Wang, R. E. Reiter J. W. Said (2006) An inverse relation between COX-2 and E-cadherin expression correlates with aggressive histologic features in prostate cancer. Appl. Immunohistochem. Mol. Morphol. 14, 375 383.
28. Sheng, H., C. S. Williams, J. Shao, P. Liang, R. N. DuBois R. D. Beauchamp (1998) Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway. J. Biol. Chem. 273, 22120 22127.
29. Bickers, D. R. M. Athar (2006) Oxidative stress in the pathogenesis of skin disease. J. Invest. Dermatol. 126, 2565 2575.
30. Pegg, A. E. (2006) Regulation of ornithine decarboxylase. J. Biol. Chem. 281, 14529 14532.
31. Tang, X., A. L. Kim, D. J. Feith, A. E. Pegg, J. Russo, H. Zhang, M. Aszterbaum, L. Kopelovich, E. H. Epstein Jr., D. R. Bickers M. Athar (2004) Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/- mice. J. Clin. Invest. 113, 867 875.